tiprankstipranks
Trending News
More News >
Atea Pharmaceuticals (AVIR)
NASDAQ:AVIR
US Market

Atea Pharmaceuticals (AVIR) Income Statement

Compare
215 Followers

Atea Pharmaceuticals Income Statement

Last quarter (Q4 2024), Atea Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Atea Pharmaceuticals's net income was $-33.54M. See Atea Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 351.37M$ 48.63M
Gross Profit
$ 0.00$ -70.09M$ -260.00K$ 351.34M$ 48.61M
Operating Expenses
$ 192.95M$ 94.07M$ 130.65M$ 212.99M$ 59.66M
Depreciation and Amortization
$ 0.00$ 416.00K$ 260.00K$ 29.00K$ 19.00K
EBITDA
$ -192.95M$ -119.59M$ -110.84M$ 138.41M$ -11.01M
Operating Income
$ -192.95M$ -164.16M$ -130.65M$ 138.38M$ -11.03M
Other Income/Expenses
$ 25.49M$ 29.22M$ 11.15M$ 213.00K$ 83.00K
Pretax Income
$ -167.46M$ -134.94M$ -119.50M$ 138.59M$ -10.95M
Net Income
$ -168.38M$ -135.96M$ -115.91M$ 121.19M$ -10.86M
Per Share Metrics
Basic EPS
$ -2.00$ -1.63$ -1.39$ 1.46$ -0.13
Diluted EPS
$ -2.00$ -1.63$ -1.39$ 1.37$ -0.13
Weighted Average Shares Outstanding
84.26M 83.39M 83.25M 82.82M 82.44M
Weighted Average Shares Outstanding (Diluted)
84.26M 83.39M 83.25M 88.25M 82.44M
Currency in USD

Atea Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis